[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ilsan Cha hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":134},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,38,78,108],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100528253","an-observational-study-on-postoperative-symptoms-after-thyroidectomy-pos-t-100528253",false,"NCT06158360","An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)","A Prospective Multi-centered Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T) in Patients With Thyroid Cancer","Inclusion Criteria:\n\n* 19 years of age or older\n* Those who have been confirmed to have a malignant tumor of the thyroid gland by biopsy or imaging\n* Subjects who have undergone partial thyroidectomy or total resection within 1 month\n* Those who have agreed to the implementation of Chinese medicine treatment\n* The Eastern Cooperative Oncology Group(ECOG) performance status 0-3\n* Those who understand the content of the study and agree to participate in the study\n\nExclusion Criteria:\n\n* ○ When it is judged that other diseases other than cancer (dementia, cerebrovascular disease, severe organ failure, etc.) may have a significant effect on the decline of physical function\n\n  * When it is judged that the life expectancy is less than 3 months and sufficient follow-up cannot be carried out\n  * When emergency or major surgery or surgical intervention is required that takes precedence over postoperative treatment\n  * Pregnant and lactating women\n  * Other researchers who are judged to be unsuitable for research","ALL","19 Years",{"count":19,"type":20},500,"ESTIMATED","OBSERVATIONAL","This observational study aimed to evaluate the safety and efficacy of postoperative management in patients with thyroid cancer who received subtotal or total thyroidectomy.",[24],"Thyroid Cancer","RECRUITING","2026-03-25",{"date":28,"type":29},"2026-03-30","ACTUAL",{"date":31,"type":29},"2023-12-01",{"date":33,"type":20},"2029-12-31",{"name":35,"class":36},"Ilsan Cha hospital","OTHER",3,{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":46,"minAge":4,"maxAge":47,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":51,"briefSummary":53,"conditions":54,"keywords":58,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},"100612247","hemodynamic-effects-of-remimazolam-vs-propofol-during-robot-assisted-gynecologic-surgery-100612247","NCT07251101","Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery","A Randomized, Parallel, Open-label With Blinded Assessment Study Comparing Hemodynamic Profiles Between Remimazolam- and Propofol-based Total Intravenous Anesthesia in Patients Undergoing Robot-assisted Gynecologic Surgery","By_HD","Inclusion Criteria:\n\n* Female patients \\\u003C65 years of age\n* American Society of Anesthesiologists (ASA) physical status I-II\n* Scheduled to undergo robotic hysterectomy under general anesthesia\n\nExclusion Criteria:\n\n* Body mass index (BMI) \\> 35 kg\u002Fm²\n* Baseline hypotension (systolic blood pressure \\\u003C100 mmHg) or bradycardia (heart rate \\\u003C60 bpm)\n* History of ischemic heart disease or cardiac conduction block\n* Significant cardiopulmonary disease, including hypoxemia (SpO₂ \\\u003C90%), uncontrolled asthma, or chronic obstructive pulmonary disease (COPD)\n* Use of inhalational anesthetics during anesthesia\n* Conversion from robotic\u002Flaparoscopic surgery to open laparotomy","FEMALE","65 Years",{"count":49,"type":20},58,"INTERVENTIONAL",[52],"NA","This single-center study at CHA Ilsan Medical Center compares intraoperative hemodynamics between remimazolam- and propofol-based total intravenous anesthesia (TIVA) in patients undergoing robot-assisted gynecologic surgery requiring pneumoperitoneum and steep Trendelenburg positioning.",[55,56,57],"Anesthesia, Intravenous","Hemodynamic Stability","Gynecologic Surgery",[59,60,61,62,63,64,65,66,67],"remimazolam","propofol","hemodynamics","laparoscopic surgery","general anesthesia","Trendelenburg position","pneumoperitoneum","gynecologic surgery","total intravenous anesthesia (TIVA)","NOT_YET_RECRUITING","2026-03-23",{"date":71,"type":29},"2026-03-27",{"date":73,"type":20},"2026-05-02",{"date":75,"type":20},"2027-12-30",{"name":35,"class":36},2,{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":86,"targetDuration":4,"studyType":50,"phases":88,"briefSummary":90,"conditions":91,"keywords":94,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},"100586855","phase-4-viscum-album-for-tnbc-on-adjuvant-pembrolizumab-100586855","NCT06920810","Viscum Album for TNBC on Adjuvant Pembrolizumab","Efficacy and Safety of Viscum Album in Patients With Triple-negative Breast Cancer Undergoing Immune Checkpoint Inhibitors","TNBNOBA","Inclusion Criteria:\n\n1. Adults aged 19 years or older\n2. Histologically confirmed diagnosis of triple-negative breast cancer\n3. ECOG Performance Status of 0 or 1\n4. Completed surgery and radiotherapy for localized disease, and either (a) requires adjuvant chemotherapy including immune checkpoint inhibitors, or (b) has initiated such therapy within 3 cycles\n5. Laboratory values meeting the following criteria:\n\n   Absolute Neutrophil Count (ANC) ≥ 1,500\u002FμL Platelet count (PLT) ≥ 100,000\u002FμL Hemoglobin (Hb) ≥ 9.0 g\u002FdL Albumin ≥ 3.0 g\u002FdL Acceptable levels of creatinine, total bilirubin, AST, and ALT ≤ 3 × upper limit of normal (ULN)\n6. Able to understand the study information and voluntarily provide written informed consent\n\nExclusion Criteria:\n\n1. Presence of distant metastasis\n2. Uncontrolled pleural effusion, ascites, or pericardial effusion\n3. Other non-cancer comorbidities (e.g., dementia, cerebrovascular disease, end-stage renal disease) that are expected to significantly impair physical function\n4. Pregnant or breastfeeding women\n5. Estimated life expectancy of less than 3 months, making adequate follow-up unlikely\n6. Any other medical condition that may interfere with study results or any situation in which, in the investigator's judgment, participation is not appropriate",{"count":87,"type":20},40,[89],"PHASE4","The goal of this clinical trial is to evaluate the efficacy and safety of Viscum album extract when used in combination with pembrolizumab as adjuvant chemotherapy in adult patients (aged 19 and older) who have been diagnosed with malignant neoplasm of unilateral breast and have completed surgery.\n\nThe main questions it aims to answer are:\n\nDoes the addition of Viscum album improve clinical outcomes when combined with pembrolizumab as adjuvant chemotherapy? Is Viscum album safe and tolerable for use in this patient population?",[92,93],"Breast Cancer","Triple Negative Breast Cancer",[95,96,97,98],"triple negative breast cancer","adjuvant chemotherapy","pembrolizumab","mistletoe","2025-04-02",{"date":101,"type":29},"2025-04-10",{"date":103,"type":29},"2025-03-19",{"date":105,"type":20},"2028-12-31",{"name":35,"class":36},1,{"id":109,"slug":110,"hasResults":11,"nctId":111,"briefTitle":112,"officialTitle":113,"acronym":114,"eligibilityCriteria":115,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":116,"enrollmentInfo":117,"targetDuration":4,"studyType":50,"phases":119,"briefSummary":120,"conditions":121,"keywords":123,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":128,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":107},"100580654","nasal-steam-therapy-for-post-extubation-respiratory-events-100580654","NCT06840106","Nasal Steam Therapy for Post-extubation Respiratory Events","Effectiveness and Safety of Nasal Herbal Steam Therapy for Post-extubation Respiratory Events : Pragmatic Randomized Controlled, Parallel Grouped Study","PURE","Inclusion Criteria:\n\n* Age of 19 to 69 years\n\n  * Those who underwent surgical removal of the thyroid gland under endotracheal intubation due to a thyroid tumor\n\n    * American Society of Anesthesiologists (ASA) status I or II\n\n      * Those who developed upper respiratory symptoms after surgery ⑤ Voluntarily decided to participate in this clinical trial and signed the informed consent form\n\nExclusion criteria:\n\n* Those diagnosed with symptomatic gastroesophageal reflux disease\n\n  * Chronic cough lasting for more than 3 months prior to surgery, including bronchial asthma and chronic obstructive pulmonary disease (COPD)\n\n    * Those who developed other respiratory infections within the past month ④ Those who are taking or are required to take other medications that may interfere with the interpretation of the treatment effect or results\n\n      * Those who are scheduled to undergo additional major treatments such as reoperation, chemotherapy, and radiotherapy during the clinical trial period ⑥ Pregnant women, breastfeeding women, and those who plan to become pregnant during the study period ⑦ Others who are expected to have difficulty complying with the treatment, visits, and questionnaires stipulated in this protocol at the discretion of the medical staff","69 Years",{"count":118,"type":20},66,[52],"The effect of symptom improvement of nasal steam strategy compared to routine management strategy for upper respiratory symptoms occurring after endotracheal intubation in patients aged 19 years or older who underwent surgical removal under anesthesia requiring endotracheal intubation was evaluated by the difference in the results of Wisconsin Upper Respiratory Symptom Survey",[24,122],"Intubation",[124,125,126],"thyroid cancer","post-extubaton","upper respiratory event","2025-03-27",{"date":99,"type":29},{"date":130,"type":29},"2025-02-18",{"date":132,"type":20},"2027-12-31",{"name":35,"class":36},""]